Showing results (1-10 of 102) with videos related to
Sort By:
Pageof 11
Drug Discovery Today|December 24, 2003
Fluorescence readouts in HTS: no gain without pain?Philip Gribbon, Andreas SewingJournal of Biomolecular Screening|September 1, 2006
The application of fluorescence lifetime readouts in high-throughput screeningJulian Moger, Philip Gribbon, Andreas Sewing, et al.Combinatorial Chemistry & High Throughput Screening|June 22, 2006
Analysing the output from primary screeningDawn Nowlin, Patrick Bingham, Andrew Berridge, et al.Journal of Biomolecular Screening|June 9, 2006
A novel method for analyzing [Ca2+] flux kinetics in high-throughput screeningPhilip Gribbon, Chris Chambers, Kaupo Palo, et al.Journal of Biomolecular Screening|April 1, 2005
Evaluating real-life high-throughput screening dataPhilip Gribbon, Richard Lyons, Philip Laflin, et al.Expert Opinion on Drug Discovery|July 25, 2012
Exemplification of the challenges associated with utilising fluorescence intensity based assays in discoverySheraz Gul, Philip GribbonCurrent Drug Discovery Technologies|February 14, 2006
Experiences in implementing uHTS--cutting edge technology meets the real worldPhilip Gribbon, Sabine Schaertl, Malcolm Wickenden, et al.Drug Discovery Today|May 30, 2009
New working paradigms in research laboratoriesWilma Keighley, Andreas SewingDrugs|March 7, 2022
Drug Repurposing to Target Neuroinflammation and Sensory Neuron-Dependent PainMarco Sisignano, Philip Gribbon, Gerd GeisslingerACS Omega|August 28, 2023
Pharmacophore-Based Machine Learning Model To Predict Ligand Selectivity for E3 Ligase BindersReagon Karki, Yojana Gadiya, Philip Gribbon, et al.Pageof 11